News Related to Fos-Related Antigen 1

Related coverage linked through entity extraction aliases.

Brigatinib and Fructose: New Strategies to Overcome Ovarian Cancer Recurrence

Aug 01, 2026

Preclinical studies reveal that fructose promotes metastasis in ovarian cancer by reducing cell adhesion, while brigatinib enhances PARP inhibitor efficacy by blocking an early adaptive resistance mechanism. The findings suggest dietary modifications and repurposing a lung cancer drug could improve outcomes for high-grade serous ovarian cancer patients.

New Cancer Research Shows Promise in Blood Cancer, Prostate Cancer, and Ovarian Cancer Treatment

Mar 17, 2026

Recent studies demonstrate high response rates for antibody-drug conjugate in rare blood cancer, improved outcomes with metastasis-directed radiation in prostate cancer, and a novel drug combination strategy for ovarian cancer resistance.